Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Use this KZR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KZR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KZR SEC filings page. Lician reads the product cache first so this HTML stays unique to Kezar Life Sciences Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KZR income, balance, and cash tables.